Integra Lifesciences Holdings Corp
Could not find a ticker for this position, may be a filing error
A maker of surgical and medical devices used by neurosurgeons, reconstructive surgeons, and general surgeons. Its best-known product is the Integra Dermal Regeneration Template, a bioengineered "artificial skin" scaffold that helps severe burn victims grow new skin. The company was founded in 1989 by Dr. Richard Caruso, who licensed the collagen-scaffold technology developed at MIT and Harvard. Its name reflects the product's purpose: the matrix integrates with the patient's own body to regenerate tissue.
0.50% Convertible Senior Notes due August 15, 2025
Granted 216.1K · Bought 2.0K · Sold 2.34M
Sold 1.78M
Granted 4.96M · Bought 52.6K · Sold 3.30M
Granted 1.01M · Sold 648.1K
Granted 113.8K · Bought 55.9K
Granted 129.9K · Sold 46.6K
Granted 140.0K · Sold 65.1K
Granted 78.6K · Sold 26.7K
Granted 149.5K · Sold 57.3K
Granted 120.2K · Sold 89.6K
Granted 90.1K · Sold 15.7K
Granted 75.0K
Granted 97.2K · Bought 2.6K · Sold 14.6K
Granted 33.6K · Bought 10.0K
Granted 65.4K
Granted 70.9K · Sold 32.3K
Granted 36.2K
Granted 41.5K
Granted 32.1K · Bought 9.0K
Granted 46.3K
Granted 35.7K
Granted 47.5K · Sold 8.0K
Granted 220.6K · Sold 131.9K
Granted 6.3K · Sold 16.8K
Granted 675.6K · Sold 536.9K
Granted 23.7K · Sold 21.5K
Granted 125.1K · Sold 87.5K
Granted 30.3K · Bought 7.8K
Granted 22.7K
Granted 33.1K
Granted 2.5K · Sold 3.0K
Granted 67.0K · Sold 38.3K
Granted 36.3K · Sold 23.9K
Granted 87.9K · Sold 94.0K
Granted 15.2K · Bought 1.9K
Granted 22.4K · Sold 6.7K
Granted 400.1K · Sold 342.9K
Granted 6.1K
Granted 16.8K · Sold 28.0K
Granted 12.5K · Sold 5.3K
Granted 19.7K · Sold 10.4K
Granted 8.3K
Granted 21.9K · Sold 8.9K
Granted 15.9K · Sold 12.5K
Granted 2.2K · Sold 12.9K
Granted 4.4K
Granted 1.4K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Caruso Richard E10% owner · 41 transactions | — | 21.52Mas of Jun 2020 | 216.1K | 2.0K | 2.34M |
| Tru St Partnership, L.P.10% owner · 9 transactions | — | 8.52Mas of Mar 2022 | — | — | 1.78M |
| Essig StuartDirector · 153 transactions | — | 2.67Mas of Aug 2025 | 4.96M | 52.6K | 3.30M |
| Arduini Peter JPresident & CEO, Director · 118 transactions | — | 216.7Kas of Sep 2021 | 1.01M | — | 648.1K |
| Hill Barbara BDirector · 32 transactions | — | 187.5K | 113.8K | 55.9K | — |
| Schade Christian SDirector · 34 transactions | — | 90.0Kas of May 2025 | 129.9K | — | 46.6K |
| Bradley KeithDirector · 109 transactions | — | 88.3K | 140.0K | — | 65.1K |
| Murphy Raymond G.Director · 38 transactions | — | 82.8Kas of May 2024 | 78.6K | — | 26.7K |
| Davis Robert T. Jr.EVP & President, TT · 119 transactions | — | 66.4K | 149.5K | — | 57.3K |
| Sullivan James MDirector · 32 transactions | — | 62.6Kas of May 2018 | 120.2K | — | 89.6K |
| McBreen Michael J.EVP & President, CSS · 59 transactions | — | 60.7K | 90.1K | — | 15.7K |
| Anderson Carrie LExecutive Vice President & CFO · 16 transactions | — | 57.8Kas of Jul 2022 | 75.0K | — | — |
| Schwartz EricEVP, Chief Legal Officer & Sec · 54 transactions | — | 56.0Kas of Mar 2025 | 97.2K | 2.6K | 14.6K |
| Morel Donald E JrDirector · 15 transactions | — | 55.8Kas of May 2022 | 33.6K | 10.0K | — |
| Knight Lea DanielsEVP & Chief Financial Officer · 9 transactions | — | 50.5K | 65.4K | — | — |
| Reuvers Daniel L.CVP,PRES - CODMAN SPC SURGICAL · 82 transactions | — | 47.7Kas of May 2020 | 70.9K | — | 32.3K |
| Howell Lloyd JrDirector · 22 transactions | — | 44.6Kas of May 2020 | 36.2K | — | — |
| Clay ShaundraDirector · 8 transactions | — | 41.5Kas of May 2025 | 41.5K | — | — |
| Graves Jeffrey ADirector · 5 transactions | — | 41.1K | 32.1K | 9.0K | — |
| Singh HarvinderEVP & PRESIDENT, INTERNATIONAL · 13 transactions | — | 40.6K | 46.3K | — | — |
| Lo Renee WonlaiDirector · 4 transactions | — | 35.7Kas of May 2025 | 35.7K | — | — |
| Mosebrook JeffreySVP, Fin & Princ Acct Officer · 82 transactions | — | 35.5K | 47.5K | — | 8.0K |
| Coleman GlennExecutive Vice President & COO · 95 transactions | — | 34.6Kas of Jul 2022 | 220.6K | — | 131.9K |
| Paltridge Robert DCorp VP, Pres. Adv Woundcare · 11 transactions | — | 34.5Kas of Jul 2014 | 6.3K | — | 16.8K |
| Henneman John B IIICorpVP, CAO · 168 transactions | — | 34.2Kas of Aug 2014 | 675.6K | — | 536.9K |
| Gorelick Richard D.Corp VP, Gen Counsel & Sec · 53 transactions | — | 26.0Kas of Mar 2018 | 23.7K | — | 21.5K |
| Ogrady JudithCorpVP,Global Reg.Affairs · 134 transactions | — | 23.9Kas of Feb 2020 | 125.1K | — | 87.5K |
| De Witte JanPresident & CEO, Director · 16 transactions | — | 23.9Kas of Nov 2024 | 30.3K | 7.8K | — |
| Baltimore Thomas J JrDirector · 13 transactions | — | 22.7Kas of May 2012 | 22.7K | — | — |
| Veillon-Berteloot ChantalEVP & CHRO · 10 transactions | — | 22.2K | 33.1K | — | — |
| Nociolo Don RSenior VP, Operations · 3 transactions | — | 19.0Kas of Mar 2006 | 2.5K | — | 3.0K |
| Evoli LisaEVP & CHRO · 94 transactions | — | 18.7Kas of Mar 2023 | 67.0K | — | 38.3K |
| Mooradian JohnCorp VP, Global Ops & Supp Chn · 70 transactions | — | 17.5Kas of Feb 2020 | 36.3K | — | 23.9K |
| Holtz David BSenior VP, Finance (1) · 24 transactions | — | 16.4Kas of Dec 2006 | 87.9K | — | 94.0K |
| Ballintyn Rhonda GermanyDirector · 9 transactions | — | 15.8Kas of May 2021 | 15.2K | 1.9K | — |
| Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER · 42 transactions | — | 13.8Kas of Feb 2020 | 22.4K | — | 6.7K |
| Carlozzi Gerard SExecutive Vice President & COO · 89 transactions | — | 10.7Kas of Apr 2010 | 400.1K | — | 342.9K |
| Thiruvengadam PadmaCorp VP, Chief HR Officer · 14 transactions | — | 10.2Kas of Apr 2015 | 6.1K | — | — |
| Leonetti Deborah ACorp VP, Glbl Servs & Repair · 31 transactions | — | 8.7Kas of May 2015 | 16.8K | — | 28.0K |
| Vanlent AnneDirector · 4 transactions | — | 8.5Kas of May 2012 | 12.5K | — | 5.3K |
| Vinhais JosephCorp VP,Quality&Transformation · 56 transactions | — | 8.2Kas of Sep 2019 | 19.7K | — | 10.4K |
| Augusti Mark ACVP,PRES-ORTHO & TISSUE TECH · 10 transactions | — | 8.0Kas of Oct 2016 | 8.3K | — | — |
| Corbin Jerry ECorp VP & Corporate Controller · 27 transactions | — | 7.5Kas of Jul 2014 | 21.9K | — | 8.9K |
| Moszkowski NealDirector · 3 transactions | — | 6.9Kas of May 2013 | 15.9K | — | 12.5K |
| Larkin BrianCorp VP, Pres.Gbl Spine &Ortho · 15 transactions | — | 6.7Kas of Apr 2015 | 2.2K | — | 12.9K |
| Bellantoni Maureen BExecutive VP, CFO · 1 transaction | — | 4.4Kas of Apr 2007 | 4.4K | — | — |
| Poul MojdehPresident & CEO, Director · 4 transactions | — | 0 | 1.4K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -9.66M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.